These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 25158627)

  • 1. Systemic inflammation in chronic obstructive pulmonary disease and lung cancer: common driver of pulmonary cachexia?
    Ceelen JJ; Langen RC; Schols AM
    Curr Opin Support Palliat Care; 2014 Dec; 8(4):339-45. PubMed ID: 25158627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system.
    Op den Kamp CM; Langen RC; Minnaard R; Kelders MC; Snepvangers FJ; Hesselink MK; Dingemans AC; Schols AM
    Lung Cancer; 2012 Apr; 76(1):112-7. PubMed ID: 22018880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coming back: autophagy in cachexia.
    Penna F; Baccino FM; Costelli P
    Curr Opin Clin Nutr Metab Care; 2014 May; 17(3):241-6. PubMed ID: 24535215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathophysiology of cachexia in chronic obstructive pulmonary disease.
    Schols AM; Gosker HR
    Curr Opin Support Palliat Care; 2009 Dec; 3(4):282-7. PubMed ID: 19713853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic obstructive pulmonary disease: effects beyond the lungs.
    Balasubramanian VP; Varkey B
    Curr Opin Pulm Med; 2006 Mar; 12(2):106-12. PubMed ID: 16456379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological strategies in lung cancer-induced cachexia: effects on muscle proteolysis, autophagy, structure, and weakness.
    Chacon-Cabrera A; Fermoselle C; Urtreger AJ; Mateu-Jimenez M; Diament MJ; de Kier Joffé ED; Sandri M; Barreiro E
    J Cell Physiol; 2014 Nov; 229(11):1660-72. PubMed ID: 24615622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cachexia, survival and the acute phase response.
    Stephens NA; Skipworth RJ; Fearon KC
    Curr Opin Support Palliat Care; 2008 Dec; 2(4):267-74. PubMed ID: 19060563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear transcription factor κ B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia.
    Op den Kamp CM; Langen RC; Snepvangers FJ; de Theije CC; Schellekens JM; Laugs F; Dingemans AM; Schols AM
    Am J Clin Nutr; 2013 Sep; 98(3):738-48. PubMed ID: 23902785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer cachexia.
    Tisdale MJ
    Curr Opin Gastroenterol; 2010 Mar; 26(2):146-51. PubMed ID: 19918173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral muscle wasting in chronic obstructive pulmonary disease. Clinical relevance and mechanisms.
    Debigaré R; Côté CH; Maltais F
    Am J Respir Crit Care Med; 2001 Nov; 164(9):1712-7. PubMed ID: 11719314
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of lobectomy for non-small-cell lung cancer on respiratory function in octogenarian patients with mild to moderate chronic obstructive pulmonary disease.
    Rapicetta C; Tenconi S; Voltolini L; Luzzi L; Scala V; Gotti G
    Eur J Cardiothorac Surg; 2011 Apr; 39(4):555-9. PubMed ID: 20833558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of chronic obstructive pulmonary disease on postoperative lung function and complications in patients undergoing operations for primary non-small cell lung cancer.
    Subotic DR; Mandaric DV; Eminovic TM; Gajic MM; Mujovic NM; Atanasijadis ND; Dzeletovic PP; Andric LD; Bulajic BM; Dimitrijevic ID; Sobic DP
    J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1292-9. PubMed ID: 17976465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer.
    Lee G; Walser TC; Dubinett SM
    Curr Opin Pulm Med; 2009 Jul; 15(4):303-7. PubMed ID: 19417670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local and systemic inflammation in chronic obstructive pulmonary disease.
    Wouters EF
    Proc Am Thorac Soc; 2005; 2(1):26-33. PubMed ID: 16113466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms and treatment options for muscle wasting diseases.
    Rüegg MA; Glass DJ
    Annu Rev Pharmacol Toxicol; 2011; 51():373-95. PubMed ID: 20936944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-κB activation and polyubiquitin conjugation are required for pulmonary inflammation-induced diaphragm atrophy.
    Haegens A; Schols AM; Gorissen SH; van Essen AL; Snepvangers F; Gray DA; Shoelson SE; Langen RC
    Am J Physiol Lung Cell Mol Physiol; 2012 Jan; 302(1):L103-10. PubMed ID: 22003096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease.
    Langen RC; Gosker HR; Remels AH; Schols AM
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2245-56. PubMed ID: 23827718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the ubiquitin-proteasome pathway in muscle atrophy in cachexia.
    Attaix D; Combaret L; Béchet D; Taillandier D
    Curr Opin Support Palliat Care; 2008 Dec; 2(4):262-6. PubMed ID: 19069311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutritional status in chronic obstructive pulmonary disease: role of hypoxia.
    Raguso CA; Luthy C
    Nutrition; 2011 Feb; 27(2):138-43. PubMed ID: 21145207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchodilatation test response predictors in lung function assessment of patients with resectable lung cancer and concomitant chronic obstructive pulmonary disease.
    Zarić B; Stanić J; Milovancev A; Canak V; Andjelić B; Sarcev T; Kojicić M
    J BUON; 2006; 11(2):185-90. PubMed ID: 17318969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.